Navigation Links
Palette Life Sciences Announces the Solesta Reimbursement Assistance Program
Date:2/10/2020

Palette Life Sciences, Inc., a medical device company dedicated to assisting healthcare professionals (HCPs) to improve patient outcomes in colorectal urologic and oncologic conditions and diseases, today announced the launch of the Solesta® Reimbursement Assistance Program.

Solesta is a minimally-invasive, and easily injectable viscous gel made from two polysaccharides, Non-Animal Stabilized Hyaluronic Acid (NASHA®) and Dextranomer (Dx) microspheres.1 Solesta is the only quick, nonsurgical treatment for fecal incontinence, administered in an outpatient setting without the need for anesthesia.2 HCPs can simply follow three steps at MySolesta.com to become trained in Solesta administration and technique. Studies have shown that Solesta can help patients return to a more active lifestyle (socializing, going to work, etc.) and reduces the depression and embarrassment that is often associated with bowel control problems.3

The new Solesta Reimbursement Assistance Program provides an easy and seamless reimbursement experience for physicians prescribing Solesta for their patients. The program minimizes barriers that can delay or prevent access to Solesta by providing personalized reimbursement support to physicians and their patients. Physicians simply complete the Service Request Form located on MySolesta.com and submit it to the Solesta Reimbursement Assistance Program. This one-step program for physicians and their staff assumes no financial risk for product acquisition. Once approved, Solesta will be shipped directly to the physician’s office.

“In past years, it was nearly impossible for physicians and patients to receive reimbursement for Solesta. We physicians had to endure financial risk in ordering Solesta for our patients and patients often found the product unaffordable, at times,” said Dr. Zuri Murrell, Los Angeles based colorectal surgeon and specialist. “The new Solesta Reimbursement Assistance Program mitigates the reimbursement problem. My office staff was pleasantly surprised with the simplicity and effectiveness of the new reimbursement program. In the short amount of time that the program has existed, many patients have received the Solesta treatment at a reasonable cost.”

"Seeking reimbursement for any product can be a time-consuming process for you and your office staff. When it comes to product reimbursement for Solesta, we’re here to help," said Richard Low, Head of Marketing, Palette Life Sciences. “The program is designed to help offices save time and energy while keeping physicians and their staff informed every step of the way.”

Other resources available at MySolesta.com include more detailed clinical and procedure training information for physicians, as well as education materials for patients in both written and video formats, so that they know what to expect with the Solesta treatment. The site also includes a Physician Locator for patients.

For more information on the Solesta Reimbursement Assistance Program, call 1-877-546-7150; email info@palettelifesciences.com or visit MySolesta.com.

About Solesta

Solesta®, a Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer gel, is a tissue bulking agent that is injected into the submucosal layer of the anal canal for treatment of Fecal Incontinence in adults. It’s a minimally invasive, outpatient procedure that improves Quality of Life and has been proven effective for up to 36 months.1 Learn more at MySolesta.com.

About Palette Life Sciences

Palette Life Sciences is focused on providing a wide range of products and services that improve quality of life for patients. Led by experienced healthcare executives, the initial company strategy is to transform applications of existing technologies to bring forward novel solutions for underserved conditions. Palette Life Sciences, Inc. is a wholly owned subsidiary of Pharmanest AB headquartered in Stockholm, Sweden. Learn more at MySolesta.com and palettelifesciences.com.    

References

1.    Cerwinka WH, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid in children. Adv Urol. 2008;513854.

2.    Solesta [Package Insert]. Santa Barbara, CA: Palette Life Sciences.

3.    Graf W, Mellgren KE, et al; for NASHA Dx study group. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, shame-controlled trial. Lancet. 2011;377(9770):977-1003.

Solesta® and NASHA® are registered trademarks. All rights reserved.

Important Safety Information: http://www.mysolesta.com/important-safety-information

APM088A

Read the full story at https://www.prweb.com/releases/palette_life_sciences_announces_the_solesta_reimbursement_assistance_program/prweb16897257.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine news :

1. The Lash Palette Preorder Event Has Officially Begun
2. Pixel Film Studios Released the ProPalette Spotlight Plugin for Final Cut Pro X Today
3. BTV-Business Television Rising Stars in Life Sciences with Verisante, Vivione, biOasis, Theralase and Aurora Spine
4. Polish Academy Of Sciences awards LSUHSCs Bazan Medal
5. Global Life Sciences Consulting Firm, MAETRICS, Appoints Fortune 100 Sales Executive, R.J. Lemieux.
6. Western University of Health Sciences’ Gala Fundraiser Emphasizes Humanism and Caring
7. NSU's Graduate School of Computer and Information Sciences to Host 2nd Annual ITPalooza
8. £23m to drive advances in population health sciences research
9. NSU’s Graduate School of Computer and Information Sciences to Offer Master of Science in Management Information Systems at Regional Campuses
10. Neuro-Oncology Pioneer Who Defined Standard of Care for Brain and Spinal Tumors Joins Capital Institute for Neurosciences
11. C8 Sciences’ Activate Brain Training Program Receives Blue Ribbon Designation From IBCCES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... April 01, 2020 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... of Minnesota’s counties have lost some or all of their Title X resources. , ...
(Date:3/30/2020)... ... 30, 2020 , ... Achieve Medical Center now offers ... comprehensive and compassionate mental health and wellness services in the midst of the ... telemedicine services including initial consultations, evaluations, and follow-up care. It also allows patients ...
(Date:3/28/2020)... (PRWEB) , ... March 27, 2020 , ... ... practice OrthoSC is now offering telemedicine as an alternative approach to ... of the practice’s doctors in the comfort of their own home or office ...
(Date:3/27/2020)... MARY, Fla. (PRWEB) , ... March 27, 2020 , ... ... three-month online educational health conference for people with asthma, their families and caregivers living ... a day between March 27, 2020 and June 30, 2020, and will focus on ...
(Date:3/22/2020)... ... March 21, 2020 , ... TriageLogic, a leader in ... organizations, and health centers can use for patient care during the COVID-19 crisis. ... professionals are working around the clock to implement emergency support solutions for patients ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... March 27, 2020 , ... ... platform based on students' holistic portfolios, revealed that college-bound young adults are reconsidering ... is creating huge new barriers to high school senior’s path to college and ...
(Date:3/22/2020)... ... March 21, 2020 , ... Since 1988, Gwatney dealerships have strived to ... heighten over the spread of COVID-19, Gwatney Mazda is pleased to announce two new ... of the Memphis community. , The dealership’s new Home Test Drives and Delivery ...
(Date:3/20/2020)... ... March 20, 2020 , ... ... many Frederick County families. Many of the most vulnerable community members are those ... we know as ALICE (Asset Limited, Income Constrained, Employed). Today, these ALICE households ...
Breaking Medicine Technology: